Not Signed In - [ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Hantavirus Pulmonary Syndrome |
|
|
Clinical Trial: Efficacy of Tiotropium in Patients of African Descent with Chronic Obstructive Pulmonary Disease
This study is currently recruiting patients.
|
Purpose
The purpose of this study is to look at the benefits of tiotropium, an approved drug for the treatment of bronchospasm associated with COPD (chronic obstructive pulmonary disease), in a population of patients with COPD who are of African American descent.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Chronic Obstructive Pulmonary Disease | Drug: Tiotropium Bromide Inhalation Powder | Phase IV |
MedlinePlus related topics: COPD (Chronic Obstructive Pulmonary Disease)
Study Type: Interventional
Study Design: Treatment
Further Study Details:
Study start: June 2004; Expected completion: September 2005
Eligibility
Ages Eligible for Study: 40 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Male or female of African descent
- 40 years of age or older
- Diagnosis of COPD
- History of smoking at least one pack per day for at least 10 years
- Currently experiencing shortness of breath at least with exertion
Exclusion Criteria:
- Asthma
- Recent myocardial infarction or hospitalization for congestive heart failure
Location and Contact Information
Craig S. Conoscenti, MD 203-798-4764 cconosce@rdg.boehringer-ingelheim.com
Alabama
Birmingham VA Medical Center, Birmingham, Alabama, 35294, United States; Recruiting
Cooper Green Hospital, Birmingham, Alabama, 35233, United States; Recruiting
UAB Medical Center, Birmingham, Alabama, 35294, United States; Recruiting
California
VA Greater Los Angeles Health Care System, Sepulveda, California, 91343, United States; Recruiting
UCLA David Geffen School of Medicine, Los Angeles, California, 90024, United States; Recruiting
Connecticut
Waterbury Pulmonary Associates, Waterbury, Connecticut, 06708, United States; Recruiting
Yale School of Medicine, New Haven, Connecticut, 06502, United States; Recruiting
Florida
The Bay Pines Foundation-VAMC, Bay Pines, Florida, 33744, United States; Recruiting
Emerald Coast Research Association, Panama City, Florida, 32405, United States; Recruiting
Georgia
Emory Crawford Long, Atlanta, Georgia, 30308, United States; Recruiting
Louisiana
LSU MC-Shreveport Div Pulmonary-Critical Care Medicine, Shreveport, Louisiana, 71103, United States; Recruiting
LSU School of Medicine, New Orleans, Louisiana, 70112, United States; Recruiting
New York
Bronx VA Pulmonary Section, Bronx, New York, 10468, United States; Recruiting
North Carolina
Pulmonary and Critical Care, Greenville, North Carolina, 27834, United States; Recruiting
Pennsylvania
Arcuri Clinical Research, Philadelphia, Pennsylvania, 19142, United States; Not yet recruiting
Temple University Hospital, Philadelphia, Pennsylvania, 19140, United States; Recruiting
South Carolina
Spartanburgh Pharmceutical Research, Spartanburg, South Carolina, 29307, United States; Recruiting
Low Country Lung and Critical Care P.A., Charleston, South Carolina, 29406, United States; Recruiting
Texas
Ben Taub Gen. Hospital Baylor College of Medecine, Houston, Texas, 77030, United States; Recruiting
M.E. D. VA Medical Center Pulmonary Section, Houston, Texas, 77030, United States; Recruiting
More Information
Study ID Numbers: BI-205.294
Record last reviewed: March 2005
Last Updated: April 1, 2005
Record first received: March 31, 2005
ClinicalTrials.gov Identifier: NCT00106821
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: March 2005
Last Updated: April 1, 2005
Record first received: March 31, 2005
ClinicalTrials.gov Identifier: NCT00106821
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Arenaviruses (MayoClinic)
email this page
print this page
bookmark this page
feedback on this page
